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Surgical treatment of trauma to the cranial sinuses is tech-
nically difficult, particularly at the skull base, and is beset by
complications which can result in considerable blood loss and
haemodynamic disturbance. An intractable bleed often leads
to exsanguination3 and finally to on-table death. In cases
where life-saving haemostasis is achieved, persistent hypo-
tension and decrease of cerebral perfusion can cause sig-
nificant secondary brain injury.10 Furthermore, such massive
blood loss can lead to coagulopathy; in recent years, rFVIIa
(recombinant factor VIIa) has been used widely in these
cases.7 The safety of rFVIIa administration to people with
brain injury is under evaluation, with particular attention to
the risks posed by post-traumatic thromboses occurring in the
major cerebral veins.1,6,8
Case history
A 47-year-old man (body weight 102 kg, isolated head injury,
Glasgow Coma Scale Score GCS 13) was admitted as an
emergency 2 h after a road accident. Within the following
minutes, his neurological state deteriorated and the signs of
high intracranial pressure and resultant brain injury were
observed (GCS 5). The clinical picture indicated a subtentor-
ial herniation, and the man was immediately transferred to
the operating theatre. No imaging was performed preopera-* Corresponding author. Tel.: +48 81 718 75 12;
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Open access under the Elsevier OA license.tively. A left-sided craniotomy was carried out at the site of
visible and palpable fracture of the parietal and squamous
temporal bones. Extradural and subdural haematomas were
found over almost the entire left hemisphere as well as a
small dural wound in the parietal area. During evacuation of
the haematoma,massive bleeding occurred at the base of the
skull. The craniotomy was extended to 2 cm above the
external auditory meatus and a number of bone fragments
were removed. The source of bleeding (10 ml/kg body
weight/min) was found to be a breach (6 mm  5 mm) in
the sigmoid sinus wall, caused by one of the bony fragments
removed from the primary fracture site. The only possible
method of decreasing the bleeding was to pack with a fibrin
sponge fixed with a strap of gauze. Partial haemostasis was
achieved and blood loss decreased to 3—4 ml/kg body
weight/min. The dural defect in the roof of the left sigmoid
sinus was covered with a piece of temporalis muscle fixed
with a strap of gauze (Fig. 1), and 9.6 mg rFVIIa was infused
intravenously (94 mg/kg body weight). At this stage blood loss
was below 1 ml/kg body weight/min and progressively
decreasing, so the haemostatic effect was deemed accep-
table. After 15 min blood loss had ceased. A second 9.6 mg
dose of rFVIIa was administered 60 min after the first dose.
During surgery the patient received 19 units red cell con-
centrate, 12 units fresh frozen plasma and 12 l crystalloid.
International normalised ratio (INR) values of 1.2, 1.6 and
1.2 from three consecutive preoperative coagulation
screens, performed during the sustained haemorrhage and
after the administration of the first dose of rFVIIa, were
normal or slightly raised (normal range 0.8—1.1). This equa-
ted to normal or slightly prolonged prothrombin times of 12,
18, and 11 s (normal range 12—16 s). D-dimers increased from
Figure 1 Computed tomography on the first postoperative day
shows mild cerebral oedema and the gauze strap fixing the plug
on the lacerated left sigmoid sinus wall.
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range 0—0.5 mg/ml) and activated partial thromboplastin
time continued to rise throughout, with values of 25, 27
and 36 s (normal range 27—36 s). The platelet count dropped
from 270 K/ml before blood loss, to 40 K/ml after rFVIIa
infusion. During fluid-catecholamine resuscitation, pro-
longed hypotension was observed (MAP < 50 mmHg in sum-
marised time of about 1 h).
When the man was haemodynamically stable and cate-
cholamine infusions were not necessary (20 h after surgery),
the straps of gauze were removed. However, 5 days later
brain death was diagnosed (GCS 3, Glasgow Outcome Score 1)
and, after a further day, organs for transplantation were
taken. During autopsy, no signs of thrombosis were seen.
Discussion
The results of surgical treatment of bleeding depend partly
on the possible approaches to the area of injury. In this
particular case, the main problem was difficulty in effec-
tively securing packing material to the sinus wall. High
intracranial pressure and high blood flow instantly removed
any packing applied, necessitating the use of straps of gauze
as fixing material. Despite a decrease in the rate of bleeding,
haemostasis was still deemed unsatisfactory and rFVIIa was
administrated to enhance local haemostasis.
In this case, the lethal brain injury was associated with
prolonged hypotension and decreased brain perfusion, impli-
cating an ischaemic pathology. The use of a rapid infusionsystem3 did not succeed in this case. Neither tight control of
blood pressure nor correction of rapidly developed hypovo-
laemia were achieved.
The mechanism of action of activated factor VII is depen-
dent on the availability of tissue factor at the site of vascular
damage,4 so a piece of crushedmuscle was applied to present
a high local concentration of tissue factor. The dosage and
administration of rFVIIa was based on the Israeli experience
of managing life-threatening bleeding of gunshot victims who
had extensive retroperitoneal injuries.5
Interesting findings in this case include a lack of throm-
bosis in the sigmoid sinus after direct packing and rFVIIa
administration, in contrast to a report of cerebral sinus
thrombosis observed after VIIa treatment of a casualty with
multiple trauma including head injury.8 Cerebral vein throm-
bosis as a result of head trauma has been widely reported
among both children9 and adolescents.2 However, adminis-
tration of rVIIa in cases of brain trauma has not been asso-
ciated with an increased risk of thromboembolic events.6
In our opinion, direct packing and simultaneous rFVIIa
infusion for the treatment of cerebral sinus injuries requires
further study, but the cessation of bleeding observed in our
case seems promising.
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